• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

扩大氯氮平在州立监狱中的使用:北卡罗来纳州经验综述。

Expanding Clozapine Use in State Prisons: A Review of the North Carolina Experience.

作者信息

Pruette Megan E, Zarzar Theodore R, Sheitman Brian B

机构信息

Department of Psychiatry, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.

North Carolina Department of Public Safety-Prisons, Raleigh, North Carolina, USA.

出版信息

J Correct Health Care. 2023 Apr;29(2):109-114. doi: 10.1089/jchc.21.06.0059. Epub 2023 Jan 31.

DOI:10.1089/jchc.21.06.0059
PMID:36720076
Abstract

The prevalence of serious mental illnesses in prisons is estimated to be significantly higher than in the community. The antipsychotic medication clozapine is very effective in managing treatment-resistant psychosis and may also reduce suicidal and self-injurious behaviors but is underused due to several logistic challenges. A partnership between the North Carolina prison system and University of North Carolina School of Medicine established a consultative system for clozapine initiations that has led to a 390% increase in the number of incarcerated people using clozapine over a 5-year period. This article reviews the benefits and challenges of clozapine use in corrections based on the North Carolina experience and practical strategies on how to expand use in a prison system.

摘要

据估计,监狱中严重精神疾病的患病率远高于社区。抗精神病药物氯氮平在治疗难治性精神病方面非常有效,还可能减少自杀和自伤行为,但由于一些后勤方面的挑战,其使用不足。北卡罗来纳州监狱系统与北卡罗来纳大学医学院建立了一个氯氮平启动咨询系统,该系统使得在五年时间里,使用氯氮平的被监禁人员数量增加了390%。本文基于北卡罗来纳州的经验,回顾了在惩教机构使用氯氮平的益处和挑战,以及如何在监狱系统中扩大其使用的实用策略。

相似文献

1
Expanding Clozapine Use in State Prisons: A Review of the North Carolina Experience.扩大氯氮平在州立监狱中的使用:北卡罗来纳州经验综述。
J Correct Health Care. 2023 Apr;29(2):109-114. doi: 10.1089/jchc.21.06.0059. Epub 2023 Jan 31.
2
Clozapine Reduces Self-Injurious Behavior in a State Prison Population.氯氮平可减少州立监狱人群的自伤行为。
J Am Acad Psychiatry Law. 2019 Mar;47(1):61-67. doi: 10.29158/JAAPL.003818-19. Epub 2019 Feb 19.
3
Effect of Clozapine on Time Assigned to Restrictive Housing in a State Prison Population.氯氮平对州立监狱人群中被分配至限制性住房的时间的影响。
J Am Acad Psychiatry Law. 2021 Dec;49(4):581-589. doi: 10.29158/JAAPL.210011-21. Epub 2021 Sep 3.
4
Clozapine Reduces Recurrent Suicidal and Self-Injurious Behavior in Treatment-Refractory Incarcerated Individuals.氯氮平可减少治疗抵抗性监禁个体的复发性自杀和自伤行为。
J Correct Health Care. 2022 Oct;28(5):329-335. doi: 10.1089/jchc.21.02.0014. Epub 2022 Sep 30.
5
A Legal Right to Clozapine Therapy for Incarcerated Individuals With Treatment-Resistant Schizophrenia.被监禁的、有治疗抵抗性精神分裂症的个体获得氯氮平治疗的合法权利。
Psychiatr Serv. 2021 Apr 1;72(4):482-484. doi: 10.1176/appi.ps.202000845. Epub 2021 Feb 17.
6
The effect of clozapine on self-injurious behavior.氯氮平对自伤行为的影响。
J Autism Dev Disord. 1995 Dec;25(6):611-26. doi: 10.1007/BF02178191.
7
Sustained impacts of North Carolina prison therapeutic diversion units on behavioral outcomes, mental health, self-injury, and restrictive housing readmission.北卡罗来纳州监狱治疗分流单位对行为结果、心理健康、自伤和限制居住再入院的持续影响。
Prev Med. 2022 Nov;164:107318. doi: 10.1016/j.ypmed.2022.107318. Epub 2022 Oct 22.
8
Suicide Mortality Among Formerly Incarcerated People Compared With the General Population in North Carolina, 2000-2020.2000-2020 年北卡罗来纳州前囚犯与普通人群的自杀死亡率比较。
Am J Epidemiol. 2024 Feb 5;193(3):489-499. doi: 10.1093/aje/kwad214.
9
Mortality and Self-Harm in Association With Clozapine in Treatment-Resistant Schizophrenia.氯氮平治疗抵抗性精神分裂症相关的死亡率和自伤行为。
Am J Psychiatry. 2017 Oct 1;174(10):990-998. doi: 10.1176/appi.ajp.2017.16091097. Epub 2017 Jul 28.
10
Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.针对对当前药物治疗反应不佳或不耐受的精神分裂症患者,开展传统抗精神病药物与新型非典型药物对比,以及新型非典型药物与氯氮平对比的随机对照试验。
Health Technol Assess. 2006 May;10(17):iii-iv, ix-xi, 1-165. doi: 10.3310/hta10170.

引用本文的文献

1
Psychiatric and legal considerations for ketamine treatment within prison settings.监狱环境中氯胺酮治疗的精神科和法律考量
Front Psychiatry. 2024 Apr 18;15:1316108. doi: 10.3389/fpsyt.2024.1316108. eCollection 2024.